Brief: Cardiff Oncology Reports Q4 And Full Year 2022 Results And Provides Business Update
02/03/2023 21:26
March 2 (Reuters) - Cardiff Oncology Inc CRDF.O :
* CARDIFF ONCOLOGY REPORTS FOURTH QUARTER AND FULL YEAR 2022
RESULTS AND PROVIDES BUSINESS UPDATE
* CARDIFF ONCOLOGY INC - STRONG CASH FINANCIAL POSITION OF
APPROXIMATELY $105.3 MILLION AT DECEMBER 31, 2022; PROJECTED
RUNWAY INTO 2025
Source text for Eikon: ID:nPn5S9t7qa
Further company coverage: CRDF.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cardiff Oncology
See all newsBrief: Cardiff Oncology Receives FDA Orphan Drug Designation For Onvansertib In Chronic Myelomonocytic Leukemia
Corrected: Cardiff Oncology Q2 operating expenses fall on lower R&D costs
Cardiff Oncology Inc expected to post a loss of 16 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Cardiff Oncology sinks on direct equity offering